All aspects of contentious intellectual property, with a particular emphasis on patent litigation in the pharmaceutical, biotechnology and mobile telephony fields. Recent notable cases include: IPCom v Vodafone [2023] (applications to vary final orders); Nokia v Oppo (2022) (LTE RACH preamble sequences); Optis v Apple [2022] (LTE PUCCH multiplexing); Alcon v AMO [2021] (laser cataract surgery); Teva v Janssen [2021] (SPC, prodrugs); InterDigital v Lenovo [2021] (4G – two trials); Illumina v MGI [2020] (DNA sequencing, fluorescence); IPCom v HTC [2020] (patent damages); Merck Sharp & Dohme v Wyeth [2020] (pneumococcal vaccines); Conversant v Huawei & ZTE (3G/4G mobile phones; FRAND inquiries); Aspire/Accord v Allergan [2019] (glaucoma, penetration enhancers); Emson v Hozelock [2020] & [2019] (expandable hosepipes); Philips v Asus [2019] & [2018] (mobile phones, UMTS, HSDPA, power control); Merck v The Comptroller C-567/16 [2017] (CJEU, SPC; marketing authorisations); Illumina v Premaitha [2017] (patents, ante-natal testing); Merck v Teva [2017] (SPC, HIV drugs), Novartis v Actavis [2016] (Alzheimer’s drugs); Lilly v Actavis [2016] (male erectile dysfunction); Hospira v Cubist [2016] & [2017] (antibiotics); Unwired Planet v Samsung [2016] (UMTS mobile telephone); Merck v Ono [2015] (anti-cancer antibiotics); Synthon v Teva [2015] (MS drugs); Merck v Sigma C-539/13; [2013] (CJEU, parallel imports, Specific Mechanism); Vringo v ZTE [2014] (patents, UMTS, FRAND); Teva v AZ [2014] (asthma); Philips v Nintendo [2014] (Nintendo Wii, motion controllers); AGA v Occlutech [2014] (medical devices, atrial septal occluders); Samsung v Apple [2014] (patents, mobile phones, stays); Mylan v Yeda [2014] (multiple sclerosis); Perini v PCMC [2012] damages inquiry).
Brasenose College, Oxford (1995 MA Chemistry, first); City University (1996 Diploma in Law, Distinction); Inns of Court School of Law (1997, top of year, Outstanding, Scarman scholarship).